Stafford et al. clarified that the CSF-1R inhibitor PLX3397 could prevent myeloid monocyte differentiation into TAMs, and improve the response of glioblastoma towards ionizing radiation treatment which further delays the recurrence of glioblastoma [114]. Here, CSF1R is linked to glioblastoma.